Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.
Saved in:
| Title: | Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. |
|---|---|
| Authors: | Sancho-Saldaña, Agustín1 (AUTHOR) agustinsanchosaldana@gmail.com, Gil Sánchez, Anna2 (AUTHOR) agil@irblleida.cat, Quirant-Sánchez, Bibiana3,4 (AUTHOR) bquirant.germanstrias@gcat.cat, Nogueras, Lara2 (AUTHOR) lara.noguerasp@gmail.com, Peralta, Silvia5 (AUTHOR) sipem@hotmail.com, Solana, Maria José1 (AUTHOR) solanamoga@gmail.com, González-Mingot, Cristina1 (AUTHOR) crismingot@hotmail.com, Gallego, Yhovanni1 (AUTHOR) yoga253@hotmail.com, Quibus, Laura1 (AUTHOR) lquibusr@gmail.com, Ramo-Tello, Cristina6 (AUTHOR) cramot@gmail.com, Presas-Rodríguez, Silvia6 (AUTHOR) spresas.germanstrias@gencat.cat, Martínez-Cáceres, Eva3,4 (AUTHOR) emmartinez.germanstrias@gencat.cat, Torres, Pascual2 (AUTHOR) pascual.torres@udl.cat, Hervás, José Vicente7 (AUTHOR) josevicente.hervas.garcia@gmail.com, Valls, Joan8 (AUTHOR) joanvallsmarsal@gmail.com, Brieva, Luis1 (AUTHOR) lbrieva.lleida.ics@gencat.cat |
| Source: | Journal of Clinical Medicine. May2022, Vol. 11 Issue 9, p2509-2509. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
